Effect of Low-Concentration Atropine Eye Drops in Controlling the Progression of Myopia in Children: A One- and Two-Year Follow-Up Study
.
Source: Ophthalmic Epidemiology - August 2, 2023 Category: Opthalmology Authors: Hongbo Zhang Peihua Yang Yahong Li Weixiao Zhang Shumao Li Source Type: research

A 3-year Cross-sectional Assessment of the Tianjin Child and Adolescent Large-scale Eye Study
Condition:   Myopia Intervention:   Sponsor:   Tianjin Eye Hospital Completed
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

Low molecular weight proteinuria, congenital myopia and hearing loss in a 10-year-old boy: Questions
Source: Pediatric Nephrology - August 1, 2023 Category: Urology & Nephrology Source Type: research

Low molecular weight proteinuria, congenital myopia and hearing loss in a 10-year-old boy: Answers
Source: Pediatric Nephrology - August 1, 2023 Category: Urology & Nephrology Source Type: research

Atropine, 0.01%, for Myopia Control
Slowing the progression of myopia, rather than simply treating the symptoms of blurred distance vision, has only recently gained wide popularity among clinicians, despite being studied for decades. Atropine, 1%, eye drops have long been available for cycloplegia and was the original dose studied for myopia control, but more recently, much lower concentrations have been investigated to slow myopia progression while minimizing rebound effects (loss of accrued benefit after discontinuing treatment) and adverse effects such as photophobia and near blur. Four of 6 randomized myopia control studies comparing atropine, 0.01%, wit...
Source: JAMA Ophthalmology - August 1, 2023 Category: Opthalmology Source Type: research

Evaluating the Entire Shape of the Eye With Pathologic Myopia
Luo et al describe a cross-sectional analysis using 3-dimensional magnetic resonance imaging (3-D MRI) to assess ocular deformation in patients with pathologic myopia. The authors focused on analyzing both the posterior and equatorial shape of the eyes, providing a comprehensive image of the entire eye structure.
Source: JAMA Ophthalmology - August 1, 2023 Category: Opthalmology Source Type: research

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control
This randomized clinical trial investigates if low-dose atropine, 0.01%, eye drops delivered nightly over a 2-year period can slow the progression of myopia in children aged 5 to 12 years in the US.
Source: JAMA Ophthalmology - August 1, 2023 Category: Opthalmology Source Type: research

Assessment of Ocular Deformation in Pathologic Myopia Using 3-D MRI
This study attempts to assess global ocular deformation in pathologic myopia.
Source: JAMA Ophthalmology - August 1, 2023 Category: Opthalmology Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20